US government is likely to ease export restrictions on vaccines and raw materials following the vaccination of significant native populace
About 40 per cent of India’s adult population will be fully vaccinated by November, largely through indigenous vaccine production, according to a recent Yes Securities report. By January 2022, the analysts estimate, another 20 per cent is likely to be vaccinated, thereby covering 60 per cent of the adult population. Yes Securities further estimated that by the end of this fiscal year (March 2022), about 80 per cent of the adult population will be vaccinated.
"It is pertinent to note that the vaccination threshold for herd immunity, as defined by one of WHO’s chief scientists, is 60‐70 per cent of the total population," the analysts noted.
“India’s teething troubles of vaccination coverage are likely to persist over the next month, owing to raw material scarcity for domestic manufacture. Shortage, if severe, can dent vaccination drive with 75 million of the population to be prioritised for second dose (who will be due after stipulated seven weeks of first dose), bringing the first dose to a halt and derailing the future vaccination run‐rate,” the analysts cautioned.
However, vaccine production should ramp up, June onwards, given that manufacturers are boosting capacities and the US government is likely to ease export restrictions on vaccines and raw materials following the vaccination of significant native populace, over the next 45 days. Considering that India's adult population of 1 billion will account for the largest market for US vaccines, it estimated that 20‐25 per cent of US vaccine exports will head to India.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.